top of page
News, Events and Updates
Search
Anavex Life Sciences to Present at the Cowen 39th Annual Health Care Conference 2019
Mar 6, 2019
Anavex Life Sciences Reports Publication of New Data that Show ANAVEX®2-73 Induces Cellular Recyclin
Mar 4, 2019
Anavex Life Sciences Reports Fiscal 2019 First Quarter Financial Results & Updates on Clinical Study
Feb 7, 2019
Anavex Life Sciences to Present at the 2019 BIO CEO & Investor Conference
Feb 4, 2019
Anavex Life Sciences to Announce Fiscal 2019 First Quarter Financial Results on Thursday, 2/7/2019
Jan 31, 2019
Anavex Life Sciences Announces the Appointment of Walter E Kaufmann, MD as Chief Medical Officer
Jan 2, 2019
Anavex Life Sciences Reports Fiscal Year 2018 Financial Results And Provides Clinical Study Update
Dec 12, 2018
Anavex Life Sciences to Announce 2018 Fiscal Year End Financial Results on Wednesday, 12/12/2018
Dec 10, 2018
Anavex Life Sciences Strengthens its Scientific Advisory Board with Distinguished Researcher for Cli
Nov 8, 2018
First Patient Enrolled in Anavex Life Sciences Phase 2 Clinical Trial of ANAVEX®2-73
Oct 29, 2018
Anavex Life Sciences Presents New Three-Year, Longitudinal Clinical Efficacy Data for ANAVEX®2-73
Oct 25, 2018
20
21
22
23
24
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
